Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
191.14
122.43
139.02
219.79
189.19
140.48
212.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
191.14
122.43
139.02
219.79
189.19
140.48
212.18
Raw Material Cost
134.93
93.05
93.91
138.33
122.52
99.20
125.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.05
0.05
0.00
0.13
0.00
0.01
0.14
Selling and Distribution Expenses
14.25
7.92
8.63
9.24
13.04
2.42
9.65
Other Expenses
0.82
0.68
1.29
1.05
1.54
1.04
1.22
Total Expenditure (Excl Depreciation)
157.47
107.81
115.41
158.15
150.92
112.00
147.12
Operating Profit (PBDIT) excl Other Income
33.7
14.6
23.599999999999998
61.6
38.3
28.5
65.1
Other Income
6.26
2.80
2.78
6.60
6.12
4.29
5.70
Operating Profit (PBDIT)
46.02
30.62
36.21
78.86
48.79
41.34
77.68
Interest
0.05
0.05
0.00
0.13
0.00
0.01
0.14
Exceptional Items
0.41
-0.09
0.10
-0.23
-0.87
0.57
0.30
Gross Profit (PBDT)
56.21
29.37
45.12
81.46
66.68
41.28
87.01
Depreciation
15.04
15.04
13.73
13.73
10.58
10.58
9.45
Profit Before Tax
31.34
15.44
22.58
64.76
37.34
31.31
68.38
Tax
2.54
2.11
1.16
8.24
6.20
-0.06
13.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.35
13.87
21.46
56.57
31.82
30.31
55.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
29.35
13.87
21.46
56.57
31.82
30.31
55.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.55
-0.54
-0.04
-0.06
-0.68
1.07
-0.47
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.80
13.33
21.43
56.52
31.14
31.38
55.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,551.34
1,522.24
1,507.42
1,599.58
1,542.19
1,510.42
1,480.83
Earnings per share (EPS)
0.07
0.04
0.05
0.14
0.08
0.08
0.14
Diluted Earnings per share
0.07
0.04
0.05
0.14
0.08
0.08
0.14
Operating Profit Margin (Excl OI)
12.93%
10.44%
14.17%
26.63%
16.96%
18.84%
29.47%
Gross Profit Margin
24.26%
24.9%
26.12%
35.71%
25.33%
29.82%
36.68%
PAT Margin
15.35%
11.33%
15.44%
25.74%
16.82%
21.58%
26.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 1.00% vs 17.30% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is -7.40% vs 44.65% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is -6.79% vs 23.05% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
Compare Quarterly Results Of Newland Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
191.14
0
191.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
191.14
0
191.14
Raw Material Cost
134.93
0
134.93
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.05
0
0.05
Selling and Distribution Expenses
14.25
0
14.25
Other Expenses
0.82
0.00
0.82
Total Expenditure (Excl Depreciation)
157.47
0
157.47
Operating Profit (PBDIT) excl Other Income
33.67
0.00
33.67
Other Income
6.26
0
6.26
Operating Profit (PBDIT)
46.02
0
46.02
Interest
0.05
0
0.05
Exceptional Items
0.41
0
0.41
Gross Profit (PBDT)
56.21
0
56.21
Depreciation
15.04
0
15.04
Profit Before Tax
31.34
0
31.34
Tax
2.54
0
2.54
Provisions and contingencies
0
0
0.00
Profit After Tax
29.35
0
29.35
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
29.35
0
29.35
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.55
0
-0.55
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.80
0
28.80
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,551.34
0
1,551.34
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
12.93%
0%
0.00
12.93%
Gross Profit Margin
24.26%
0%
0.00
24.26%
PAT Margin
15.35%
0%
0.00
15.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.11 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 56.13% vs -11.94% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 1.00% vs 17.30% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.88 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 116.54% vs -37.85% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -7.40% vs 44.65% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.98 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 43.17% vs -16.77% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -6.79% vs 23.05% in Dec 2024
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.93%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
